Search

Your search keyword '"Targher, G"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Targher, G" Remove constraint Author: "Targher, G" Database OAIster Remove constraint Database: OAIster
27 results on '"Targher, G"'

Search Results

1. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

2. A global research priority agenda to advance public health responses to fatty liver disease

3. Global multi-stakeholder endorsement of the MAFLD definition

4. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

5. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

6. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

7. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

8. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

9. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' [Dig Liver Dis 54 (2022) 170-182]

10. Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes

11. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

12. Global multi-stakeholder endorsement of the MAFLD definition

13. Global multi-stakeholder endorsement of the MAFLD definition

14. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

15. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

16. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases

17. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

18. All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials

19. Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials

20. Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials

21. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

22. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

23. A 'systems medicine' approach to the study of non-alcoholic fatty liver disease

25. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

26. A 'systems medicine' approach to the study of non-alcoholic fatty liver disease

27. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome

Catalog

Books, media, physical & digital resources